AstraZeneca Deepens Weight Management Push With $1.2B AI-Driven Obesity Deal With CSPC

Agreement includes eight programmes, including a clinical-ready asset, plus access to advanced AI-driven peptide drug discovery platform and innovati...

February 03, 2026 | Tuesday | News
Illumina Deepens Leadership in Proteomics and Multiomics With Completed SomaLogic Acquisition

Deeply expands leadership in proteomics and multiomics Combined capabilities bring high scalability, flexibility, and affordability into protein an...

February 03, 2026 | Tuesday | News
Origami Therapeutics and Ipsen Enter Global Collaboration to Advance Disease-Modifying Therapy for Rare Neurodegenerative Disease

- Ipsen obtains exclusive option to global license a research program for a selective disease-modifying approach to neurodegenerative diseases ...

February 02, 2026 | Monday | News
Tenpoint Therapeutics Raises $235M in Series B Financing and Credit Facility to Support YUVEZZI Launch

Tenpoint Therapeutics, Ltd., a global, commercial biotechnology company focused on developing groundbreaking treatments to rejuvenate vision in the aging...

January 30, 2026 | Friday | News
SamanTree Medical Secures €20M EIB Financing to Advance Real-Time Surgical Imaging

SamanTree Medical, a European leader in surgical imaging innovation, has secured €20 million in financing from the European Investment Bank (EIB). T...

January 28, 2026 | Wednesday | News
Japan’s J-TEC Secures National Insurance Reimbursement for JACC in Knee Osteoarthritis

-Japan Tissue Engineering Co., Ltd.(J-TEC) announced that JACC, its autologous cultured cartilage product, has been granted approval by Japan’s N...

January 28, 2026 | Wednesday | News
Parse Biosciences Launches Integrated Immune Repertoire and Whole Transcriptome Analysis in Trailmaker™

New Trailmaker functionality integrates immune repertoire and whole transcriptome data to deliver rapid, publication-ready insights Parse Bios...

January 26, 2026 | Monday | News
Exciva GmbH Raises €51 Million Series B to Advance Phase 2 Program for Alzheimer’s Agitation Therapy

Exciva GmbH, a biopharmaceutical company developing novel therapeutic compounds for the treatment of neuropsychiatric conditions, today announces the closi...

January 22, 2026 | Thursday | News
Bayer and Vanderbilt University Medical Center Form Five-Year Strategic Collaboration to Advance Innovative Therapies

-Bayer and Vanderbilt University Medical Center (VUMC) announced that they have entered a strategic five-year collaboration agreement to advance innovati...

January 21, 2026 | Wednesday | News
Organon Secures FDA Approval to Extend NEXPLANON Use to Five Years

Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, announced that th...

January 20, 2026 | Tuesday | News
Linus Health Accelerates AI-Driven Early Brain Health Detection as Dementia Burden Surges and Industry Momentum Builds

2026 is already shaping up to be a historic year for brain health as the healthcare industry confronts an urgent reality: cognitive impairment, Alzheimer...

January 19, 2026 | Monday | News
IDT Relocates Bay Area Operations to Expanded Sunnyvale Innovation Hub

Genomics leader relocates to an expanded footprint in Sunnyvale New location enables customer continuity and provides increased innovation space to driv...

January 15, 2026 | Thursday | News
Hongene Biotech Secures Gates Foundation Grant to Advance Equitable mRNA Vaccine Manufacturing

Hongene Biotech announced the receipt of a grant from the Gates Foundation to develop high-quality, affordable, and patent-free cap analogs for use ...

January 14, 2026 | Wednesday | News
Oxford Nanopore’s GridION™ Dx Receives CE and UKCA Marking in UK and Europe

Oxford Nanopore has reached a major regulatory milestone with the registration of its first In Vitro Diagnostic (“IVD”) device in the UK an...

January 13, 2026 | Tuesday | Regulatory

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close